0000939767-23-000100.txt : 20230830
0000939767-23-000100.hdr.sgml : 20230830
20230830214801
ACCESSION NUMBER: 0000939767-23-000100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230828
FILED AS OF DATE: 20230830
DATE AS OF CHANGE: 20230830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRISSEY MICHAEL
CENTRAL INDEX KEY: 0001202096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 231226781
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL M
DATE OF NAME CHANGE: 20030512
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL R
DATE OF NAME CHANGE: 20021029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wk-form4_1693446470.xml
FORM 4
X0508
4
2023-08-28
0
0000939767
EXELIXIS, INC.
EXEL
0001202096
MORRISSEY MICHAEL
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
1
0
0
President and CEO
0
Common Stock
2023-08-28
4
M
0
360000
15.31
A
945496
D
Common Stock
2023-08-28
4
F
0
303779
22.18
D
641717
D
Common Stock
1340320
I
By Trust
Common Stock
17728
I
By 401(k)
Option (right to buy)
15.31
2023-08-28
4
M
0
360000
0
D
2017-09-26
2023-09-25
Common Stock
360000
0
D
Includes 515,997 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents a "net exercise" of an outstanding stock option. The Reporting Person received 56,221 shares of Common Stock on the net exercise of a stock option to purchase 360,000 shares of Common Stock. The Issuer withheld 303,779 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on August 28, 2023 of $22.18.
Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 27, 2023.
The option, representing the right to purchase a total of 360,000 shares of Common Stock, became fully exercisable on September 26, 2020.
/s/ Nina Ayer, Attorney in Fact
2023-08-30